Annual EPS
-$20.80
-$2.20-11.83%
30 September 2022
Summary:
NeuBase Therapeutics annual earnings per share is currently -$20.80, with the most recent change of -$2.20 (-11.83%) on 30 September 2022. During the last 3 years, it has fallen by -$2.20 (-11.83%).NBSE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.66
+$1.38+67.65%
30 September 2023
Summary:
NeuBase Therapeutics quarterly earnings per share is currently -$0.66, with the most recent change of +$1.38 (+67.65%) on 30 September 2023.NBSE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$7.70
+$4.14+34.97%
30 September 2023
Summary:
NeuBase Therapeutics TTM earnings per share is currently -$7.70, with the most recent change of +$4.14 (+34.97%) on 30 September 2023.NBSE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE EPS Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | -11.8% | +84.3% | +58.1% |
5 y5 years | +67.1% | +97.5% | +84.4% |
NBSE EPS High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | -143.3% | -101.6% | -108.0% |
NeuBase Therapeutics EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$0.66(-67.6%) | -$7.70(-35.0%) |
June 2023 | - | -$2.04(-15.0%) | -$11.84(-21.1%) |
Mar 2023 | - | -$2.40(-7.7%) | -$15.00(-19.4%) |
Dec 2022 | - | -$2.60(-45.8%) | -$18.60(-10.6%) |
Sept 2022 | -$20.80(+11.8%) | -$4.80(-7.7%) | -$20.80(+3.0%) |
June 2022 | - | -$5.20(-13.3%) | -$20.20(-2.9%) |
Mar 2022 | - | -$6.00(+25.0%) | -$20.80(+6.1%) |
Dec 2021 | - | -$4.80(+14.3%) | -$19.60(+6.5%) |
Sept 2021 | -$18.60(+4.5%) | -$4.20(-27.6%) | -$18.40(+1.1%) |
June 2021 | - | -$5.80(+20.8%) | -$18.20(+13.8%) |
Mar 2021 | - | -$4.80(+33.3%) | -$16.00(-2.4%) |
Dec 2020 | - | -$3.60(-10.0%) | -$16.40(-8.9%) |
Sept 2020 | -$17.80(-71.8%) | -$4.00(+11.1%) | -$18.00(-56.0%) |
June 2020 | - | -$3.60(-30.8%) | -$40.89(-9.7%) |
Mar 2020 | - | -$5.20(0.0%) | -$45.29(-5.8%) |
Dec 2019 | - | -$5.20(-80.7%) | -$48.09(-2.4%) |
Sept 2019 | -$63.20(-31.3%) | -$26.89(+236.1%) | -$49.29(-26.8%) |
June 2019 | - | -$8.00(0.0%) | -$67.33(+6.7%) |
Mar 2019 | - | -$8.00(+25.0%) | -$63.13(-10.5%) |
Dec 2018 | - | -$6.40(-85.8%) | -$70.53(-24.8%) |
Sept 2018 | -$92.00(-56.6%) | -$44.93(+1082.3%) | -$93.73(+16.0%) |
June 2018 | - | -$3.80(-75.3%) | -$80.80(-23.0%) |
Mar 2018 | - | -$15.40(-48.0%) | -$105.00(-39.5%) |
Dec 2017 | - | -$29.60(-7.5%) | -$173.60(-23.9%) |
Sept 2017 | -$212.00(-35.4%) | -$32.00(+14.3%) | -$228.00(-18.6%) |
June 2017 | - | -$28.00(-66.7%) | -$280.00(-19.5%) |
Mar 2017 | - | -$84.00(0.0%) | -$348.00(+4.8%) |
Dec 2016 | - | -$84.00(0.0%) | -$332.00(+1.2%) |
Sept 2016 | -$328.00(+51.9%) | -$84.00(-12.5%) | -$328.00(+10.8%) |
June 2016 | - | -$96.00(+41.2%) | -$296.00(+21.3%) |
Mar 2016 | - | -$68.00(-15.0%) | -$244.00(+8.9%) |
Dec 2015 | - | -$80.00(+53.8%) | -$224.00(+3.7%) |
Sept 2015 | -$216.00(+31.7%) | -$52.00(+18.2%) | -$216.00(0.0%) |
June 2015 | - | -$44.00(-8.3%) | -$216.00(+3.8%) |
Mar 2015 | - | -$48.00(-33.3%) | -$208.00(+4.0%) |
Dec 2014 | - | -$72.00(+38.5%) | -$200.00(+19.0%) |
Sept 2014 | -$164.00(+36.7%) | -$52.00(+44.4%) | -$168.00(+16.7%) |
June 2014 | - | -$36.00(-10.0%) | -$144.00(+5.9%) |
Mar 2014 | - | -$40.00(0.0%) | -$136.00(+30.8%) |
Dec 2013 | - | -$40.00(+42.9%) | -$104.00(-13.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2013 | -$120.00(+200.0%) | -$28.00(0.0%) | -$120.00(+36.4%) |
June 2013 | - | -$28.00(+250.0%) | -$88.00(+20.3%) |
Mar 2013 | - | -$8.00(-85.7%) | -$73.15(-30.9%) |
Dec 2012 | - | -$56.00(-1500.0%) | -$105.87(+179.5%) |
Sept 2012 | -$40.00(-74.7%) | $4.00(-130.4%) | -$37.87(-52.8%) |
June 2012 | - | -$13.15(-67.7%) | -$80.20(-50.8%) |
Mar 2012 | - | -$40.72(-439.3%) | -$163.04(+28.3%) |
Dec 2011 | - | $12.00(-131.3%) | -$127.07(-15.9%) |
Sept 2011 | -$158.32(-975.9%) | -$38.32(-60.1%) | -$151.07(+113.8%) |
June 2011 | - | -$96.00(+1924.1%) | -$70.67(-465.4%) |
Mar 2011 | - | -$4.74(-60.5%) | $19.34(+3.1%) |
Dec 2010 | - | -$12.00(-128.5%) | $18.76(0.0%) |
Sept 2010 | $18.08(-144.0%) | $42.08(-802.4%) | $18.76(-166.0%) |
June 2010 | - | -$5.99(+12.4%) | -$28.41(-17.5%) |
Mar 2010 | - | -$5.33(-55.6%) | -$34.42(-35.2%) |
Dec 2009 | - | -$12.00(+135.9%) | -$53.09(+29.2%) |
Sept 2009 | -$41.09(<-9900.0%) | -$5.09(-57.6%) | -$41.09(-16.8%) |
June 2009 | - | -$12.00(-50.0%) | -$49.36(+32.1%) |
Mar 2009 | - | -$24.00(<-9900.0%) | -$37.36(+179.6%) |
Dec 2008 | - | $0.00(-100.0%) | -$13.36(+879.5%) |
Sept 2008 | $0.00(-100.0%) | -$13.36(<-9900.0%) | -$1.36(-147.5%) |
June 2008 | - | $0.00(0.0%) | $2.87(-101.9%) |
Mar 2008 | - | $0.00(-100.0%) | -$153.13(0.0%) |
Dec 2007 | - | $12.00(-231.5%) | -$153.13(-19.0%) |
Sept 2007 | -$792.00(-2300.0%) | -$9.13(-94.2%) | -$189.13(-1.5%) |
June 2007 | - | -$156.00(<-9900.0%) | -$192.00(<-9900.0%) |
Mar 2007 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2006 | $36.00(0.0%) | -$24.00(+100.0%) | $24.00(-50.0%) |
Sept 2006 | - | -$12.00(-133.3%) | $48.00(-50.0%) |
June 2006 | - | $36.00(+50.0%) | $96.00(+100.0%) |
Mar 2006 | - | $24.00(>+9900.0%) | $48.00(0.0%) |
Dec 2005 | $36.00(-25.0%) | $0.00(-100.0%) | $48.00(+300.0%) |
Sept 2005 | - | $36.00(-400.0%) | $12.00(>+9900.0%) |
June 2005 | - | -$12.00(-150.0%) | $0.00(-100.0%) |
Mar 2005 | - | $24.00(-166.7%) | $48.00(0.0%) |
Dec 2004 | $48.00(0.0%) | -$36.00(-250.0%) | $48.00(-42.9%) |
Sept 2004 | - | $24.00(-33.3%) | $84.00(+40.0%) |
June 2004 | - | $36.00(+50.0%) | $60.00(+150.0%) |
Mar 2004 | - | $24.00 | $24.00 |
Dec 2003 | $48.00 | - | - |
FAQ
- What is NeuBase Therapeutics annual earnings per share?
- What is the all time high annual EPS for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for NeuBase Therapeutics?
- What is NeuBase Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for NeuBase Therapeutics?
What is NeuBase Therapeutics annual earnings per share?
The current annual EPS of NBSE is -$20.80
What is the all time high annual EPS for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual earnings per share is $48.00
What is NeuBase Therapeutics quarterly earnings per share?
The current quarterly EPS of NBSE is -$0.66
What is the all time high quarterly EPS for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly earnings per share is $42.08
What is NeuBase Therapeutics TTM earnings per share?
The current TTM EPS of NBSE is -$7.70
What is the all time high TTM EPS for NeuBase Therapeutics?
NeuBase Therapeutics all-time high TTM earnings per share is $96.00